Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD): Initial results of the phase 2 KEYLYNK-007 study.

Simple item page
dc.contributor.authorMaio, Michele
dc.contributor.authorShapira-Frommer, Ronnie
dc.contributor.authorYap, Timothy A.
dc.contributor.authorCiuleanu, Tudor
dc.contributor.authorGomez, Henry
dc.contributor.authorHill, Andrew
dc.contributor.authorLugowska, Iwona
dc.contributor.authorOzyilkan, Ozgur
dc.contributor.authorVera, Karina
dc.contributor.authorIm, Seock-Ah
dc.contributor.authorKryzhanivska, Anna
dc.contributor.authorLysenko, Serhii
dc.contributor.authorSchenker, Michael
dc.contributor.authorStemmer, Salomon M.
dc.contributor.authorSaraf, Sanatan
dc.contributor.authorCristescu, Razvan
dc.contributor.authorJin, Fan
dc.contributor.authorGozmen, Alexander
dc.contributor.authorQuintela-Fandino, Miguel
dc.date.accessioned2022-08-25T06:41:59Z
dc.date.available2022-08-25T06:41:59Z
dc.date.issued2021
dc.identifier.issn0008-5472en_US
dc.identifier.issue13en_US
dc.identifier.urihttp://hdl.handle.net/11727/7418
dc.identifier.volume81en_US
dc.identifier.wos000680263501334en_US
dc.language.isoengen_US
dc.relation.journalCANCER RESEARCHen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleOlaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD): Initial results of the phase 2 KEYLYNK-007 study.en_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar